Clinical trials
Glaucoma trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 10 |
| Terminated | 6 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Zurich | 12 |
| University Hospital, Basel, Switzerland | 7 |
| Sensimed AG | 6 |
| Association for Innovation and Biomedical Research on Light and Image | 2 |
| Dr. Kaweh Mansouri | 2 |
| Implandata Ophthalmic Products GmbH | 2 |
| Selim Orguel | 2 |
| Swiss Vision Network | 2 |
| iSTAR Medical | 2 |
| EyeTechCare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma | 47 |
| Glaucoma, Open-Angle | 9 |
| Ocular Hypertension | 9 |
| Cataract | 4 |
| Exfoliation Syndrome | 2 |
| Choroidal Effusions | 1 |
| Diabetic Retinopathy | 1 |
| Glaucoma, Angle-Closure | 1 |
| Glaucoma, Neovascular | 1 |
| Hydrophthalmos | 1 |
Trials
Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.